Allarity Therapeutics, Inc. (ALLR)
(Delayed Data from NSDQ)
$1.54 USD
-0.04 (-2.53%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.53 -0.01 (-0.65%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ALLR 1.54 -0.04(-2.53%)
Will ALLR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ALLR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALLR
Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
ALLR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ALLR
ALLR Fell Below 20 Day Moving Average on September 19
ALLR Crossed Above 20 Day Moving Average on September 18
Is ALLR building bullish momentum? 1,2,3 Pullback Bullish shows up after declining 3.29%
ALLR forms 20 Day Moving Average Support on September 16
Technical picture remains unchanged for ALLR after it falls 1.81% on September 15